ARTICLES

There is a version of Alphatec's first quarter that reads like a growth story, and a version that reads like a warning. Both are true, and the distance between them is the most useful thing to study in spine right now. The growth story first. Surgical revenue reached $178 million, up 17% year over year, on 21% case-volume growth and a 23% increase in net new surgeon users. … [Read more...] about Strong Surgery, Soft Quarter: ATEC and the Cost of the Capital Bet

When Medtronic put Sextant on the market at the start of the 2000s, percutaneous pedicle screw fixation looked like the obvious endpoint for lumbar surgery: the same construct, a fraction of the soft-tissue damage. Nearly a quarter-century later, that endpoint has only partly arrived. MIS spine has been one of the most promising stories in the implant market for years. The … [Read more...] about Percutaneous MIS Spine Systems: Why Adoption Still Lags 25 Years After Sextant

Almost everywhere, spine belongs to the multinationals. Brazil doesn't follow the script, and the reasons run deeper than price. Run down the top of the spine market in the US, Europe or most of Asia and the same names keep showing up: Medtronic, DePuy Synthes, Stryker (VB Spine) , Globus Medical. Brazil is the odd one out. The biggest slice of the market there belongs to … [Read more...] about Why the Locals Win in Brazil | Updated 2026

Sublaminar bands occupy an unusual position in spine. They will never be a volume category in the way pedicle screws, cages or biologics are. Their role is more specific. But in complex deformity, pediatric cases or difficult fixation scenarios, that specificity is precisely what gives them value. Their value is not defined by volume, but by the specific problems they solve: … [Read more...] about Sublaminar Bands in Spine Surgery: Why This Small Fixation Market Still Matters | Updated 2026

Russia was never a transparent spine market. Large enough to matter, technically capable in selected centers, quietly dependent on imported premium technology. That was the working summary most international companies operated on before 2022. The picture has shifted since. Outside visibility has dropped, domestic industrial pressure has risen, and import substitution, long … [Read more...] about Sanctions, Titanium and Pedicle Screws: How Russia’s Spine Market Is Rebuilding Itself

What happens when the environment that built a generation of elite field reps no longer exists — and a new generation is building careers without ever knowing what they missed? There's a particular kind of clarity that comes from watching an industry transform from the inside. Veterans of spine sales describe an era when hospital access was assumed, relationships were built … [Read more...] about Hospital Access Is Gone. What Comes Next for Spine Field Sales?

Anterior cervical discectomy and fusion (ACDF) is one of the most standardized procedures in spine surgery. The workflow is familiar: decompression, controlled distraction, sizing, and insertion of a static interbody cage. For decades, this has worked reliably and predictably. So when expandable cages appeared in the cervical spine, the reaction was immediate and … [Read more...] about Expandable Cervical Cages: Innovation or Just a Niche Tool? | Updated May 2026

Spine surgery is moving toward ambulatory surgery centers. That part of the conversation is largely settled. What remains underexamined — especially at the executive level — is the commercial question underneath it: what does a sustainable spine business actually look like when the customer is no longer a large hospital system, but a cost-sensitive, operationally lean surgical … [Read more...] about The ASC Opportunity in Spine Will Be Won by Commercial Redesign, Not by Product Alone

Globus Medical’s latest results created an apparent contradiction. The company reported a very strong first quarter, raised its earnings guidance, continued to show the benefits of the NuVasive integration, and reinforced its position as one of the leading players in spine. Yet the stock did not move as many would have expected. In fact, the immediate market reaction was … [Read more...] about Globus Medical: Strong Q1, Weak Stock Reaction — Is the Market Asking for More?

Globus Medical’s first quarter 2026 results confirm something important: the company is no longer just digesting major acquisitions. It is beginning to show the operating logic behind them. The headline figures are strong, but the more relevant point is the quality of the performance. Growth came not only from Nevro, but also from the underlying business, particularly U.S. … [Read more...] about Globus Medical: Stronger in Spine, but Could DePuy Synthes’ Trauma Business Be the Next Big Move?

The Taiwanese spine market is relatively small, it has a sophisticated healthcare system, broad access to care and strong medical infrastructure. However, reimbursement discipline and price pressure remain important realities. For spine companies, this creates a demanding environment: surgeons may be open to advanced technologies, but hospitals remain highly sensitive to cost, … [Read more...] about Taiwan’s Spine Industry: Why a Small Market Could Become a Serious Export Hub

Last week, we published the news that Amplio Spine, LLC had signed a Letter of Intent to acquire the FDA-cleared KeyLift™ Expandable Interlaminar Stabilization System from FloSpine, LLC. This announcement brings interspinous and interlaminar implants back into focus. For that reason, we have updated our overview of this product category and its market, looking not only at … [Read more...] about Do Interspinous Spacers Still Have a Place in Spine Surgery? | Updated 2026

In posterior fixation, modularity is no longer just a design feature. Its real value depends on whether it gives surgeons more control during the procedure. For many years, pedicle screw systems competed around strength, simplicity and familiarity. The objective was clear: place the screw, connect the rod, reduce the construct and lock it down. But posterior spine … [Read more...] about Modular Pedicle Screws: When Adaptability Becomes the Product

India is no longer just a large emerging market for spine. It is becoming one of the most strategically important growth markets in the world, driven by a combination of rising spinal disease burden, expanding hospital infrastructure, growing access to surgery, and a domestic manufacturing base that is getting stronger every year. Depending on the market definition used, … [Read more...] about India’s Spine Market Is Moving Too Fast to Ignore

For years, the spine industry operated on one governing logic: optimize cost, maintain quality, keep inventory moving. It worked well enough that the supply chain became effectively invisible — titanium components, cobalt-chrome parts, PEEK-based products, instrument subassemblies, packaging — sourced across a global network refined over decades. Nobody questioned it much … [Read more...] about Trump’s Tariffs Didn’t Just Raise Costs. They Exposed How Fragile Spine’s Supply Chain Really Is

For years, the spine industry relied on a familiar commercial model. The best reps were not just salespeople. They were field operators, problem-solvers, surgeon supporters, and account stabilizers. They knew the procedure, managed the trays, anticipated problems in the OR, and built the kind of personal loyalty that often protected business for years. That model helped … [Read more...] about Why Spine’s Commercial Model Needs a Reset? The real elephant in the room may not be technology, but incentives

We first published this article in 2025. We are now republishing it in updated form following the latest FDA approval in the single-use spine market, including Dual, one of the newest additions to this category. Over the past two decades, spine surgery has evolved through advances in minimally invasive techniques, greater intraoperative precision, and a growing focus on … [Read more...] about Single-Use Spine Surgery Systems: The Future or Still a Niche? Leading Platforms in 2026

In MedTech, it is easy to misunderstand the role of marketing. This is a business built on relationships, service, clinical credibility, and product knowledge. Surgeons do not adopt a device because they saw a polished campaign. Hospitals do not change practice because of a clever slogan. And no brochure, however well designed, can replace the value of a strong rep in the … [Read more...] about In MedTech Sales, Does Marketing Really Matter? Yes, But Only If It Helps Sell

Turkey does not usually sit at the center of most EMEA spine market conversations, but it deserves more attention than it gets. Not because it is already one of the world’s largest spine markets in absolute value, but because it combines several growth drivers that rarely come together in one country: a large hospital base, near-universal health coverage, a meaningful private … [Read more...] about Why Turkey’s Spine Market Is Worth Watching | 2026 Update